SCHEMBL7599503

SCHEMBL7599503

Cc1cccc(Cn2nnc3ccccc32)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 3/20 0.69
GRM2 Q14416 2/20 0.69
PTK2 Q05397 4/20 0.63
TDP1 Q9NUW8 1/20 0.59
ALDH1A1 P00352 2/20 0.57
CYP11B1 P15538 1/20 0.57
CYP11B2 P19099 1/20 0.57
HPGD P15428 2/20 0.56
IDO1 P14902 1/20 0.56
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.56
TDO2 P48775 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
TP53 P04637 3/20 0.53
MAPT P10636 2/20 0.53
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22000732 0.83 GRM2 (0.75) SLC9A1GRM2PTK2TDP1CYP11B1
SCHEMBL2734889 0.82 GRM2 (1.00) SLC9A1GRM2PTK2TDP1ALDH1A1
SCHEMBL14809085 0.82 PTK2 (0.72) SLC9A1GRM2PTK2TDP1ALDH1A1
SCHEMBL9303448 0.82 PTK2 (0.72) SLC9A1GRM2PTK2TDP1ALDH1A1
SCHEMBL15338669 0.81 TDP1 (0.67) SLC9A1GRM2PTK2TDP1RAB9A
SCHEMBL21991433 0.81 HCAR3 (0.54) SLC9A1GRM2PTK2TDP1ALDH1A1
SCHEMBL19848239 0.80 GRM2 (0.66) SLC9A1GRM2PTK2TDP1ALDH1A1
SCHEMBL19911496 0.80 GRM2 (0.66) SLC9A1GRM2PTK2TDP1ALDH1A1
SCHEMBL15906162 0.80 GRM2 (0.52) SLC9A1GRM2PTK2TDP1NPC1
SCHEMBL7594126 0.78 GRM2 (0.63) SLC9A1GRM2PTK2TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486142-B2 A,A-DIFLUOROBENZYLPHOSPHONIC ACID DERIVATIVES MERCK FROSST CANADA & CO. (CA) 2002-11-26 US disclosed
EP-1244678-A1 PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) MERCK FROSST CANADA INC. (CA) 2002-10-02 EP disclosed
US-20020058644-A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) MERCK FROSST CANADA LTD. (CA) 2002-05-16 US disclosed
WO-2001046206-A1 PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) MERCK FROSST CANADA & CO. (CA) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058644-A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) PPM1B, PTPRO, PTPA SLC9A1 1138/4885GRM2 1984/4885PTK2 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.